Click on the tab to search across Lilly for additional information
Cymbalta in MDD

Cymbalta and MDD

Multidimensional Aspects of Depression

Major depressive disorder (MDD) has a broad range of symptoms, including depressed mood, loss of interest, feelings of guilt, lack of energy, decreased concentration, changes in appetite, sleep or psychomotor activity, and recurrent thoughts of death or suicidality. Other associated symptoms may also include anxiety, bodily aches and pains, and irritability.1 Treating MDD can be complex. Patients may present with a broad range of symptoms.

Cymbalta Demonstrated Broad Efficacy, Safety and Tolerability, and Once-daily Dosing in MDD

References:

  1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fourth edition, Text Revision; Washington, DC: American Psychiatric Association, 2000.
  2. Data on file, Lilly Research Laboratories: CYM20090505C, b. CYM20090505A, c. CYM20090505D, d. CYM20090506A, e. CYM20060101A.
  3. Cymbalta full Prescribing Information, 2009.

Formulary Access Finder

Cymbalta has been added to the Anthem Blue Cross Blue Shield National Preferred Formulary.

Get more information about the formulary access for Cymbalta. Download PDF files of insurance providers covering Cymbalta in your state.

Register to Receive Information From Cymbalta

Keep up-to-date on the latest developments with Cymbalta. Sign up now for our periodic emails.